tiprankstipranks
Trending News
More News >
Cartesian Therapeutics (RNAC)
NASDAQ:RNAC
US Market

Cartesian Therapeutics (RNAC) Income Statement

Compare
1,149 Followers

Cartesian Therapeutics Income Statement

Last quarter (Q4 2025), Cartesian Therapeutics's total revenue was $947.00K, a decrease of -224.77% from the same quarter last year. In Q4, Cartesian Therapeutics's net income was $-92.58M. See Cartesian Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 2.80M$ 38.91M$ 26.00M$ 110.78M$ 85.08M
Gross Profit
$ 2.80M$ 38.91M$ 26.00M$ 108.74M$ 85.08M
Operating Expenses
$ 89.50M$ 82.81M$ 112.42M$ 94.20M$ 89.67M
Depreciation and Amortization
$ 0.00$ 1.15M$ 843.00K$ 2.04M$ 1.72M
EBITDA
$ -86.70M$ -75.99M$ -235.03M$ 39.84M$ -5.16M
Operating Income
$ -86.70M$ -43.90M$ -86.42M$ 14.54M$ -4.60M
Other Income/Expenses
$ -52.79M$ -33.24M$ -152.29M$ 20.23M$ -5.12M
Pretax Income
$ -139.50M$ -77.14M$ -238.71M$ 34.77M$ -9.72M
Net Income
$ -130.30M$ -77.42M$ -219.71M$ 35.38M$ -25.69M
Per Share Metrics
Basic EPS
$ -5.02$ -2.99$ -49.76$ 7.33$ -6.74
Diluted EPS
$ -5.02$ -3.29$ -49.76$ 3.00$ -6.60
Weighted Average Shares Outstanding
25.97M 25.91M 5.17M 4.02M 3.18M
Weighted Average Shares Outstanding (Diluted)
25.97M 23.69M 5.17M 4.05M 3.18M
Currency in USD

Cartesian Therapeutics Earnings and Revenue History